Safety and Pharmacokinetic Profile of Udenafil in Healthy Mexican Adults
NCT01967264 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 83
Last updated 2013-10-22
Summary
The purpose of this study is to evaluate the safety and tolerability of Udenafil 150 mg compared to placebo.
Conditions
- Erectile Dysfunction
- Phosphodiesterase 5 Inhibitor
Interventions
- DRUG
-
Udenafil
Udenafil tablets
- DRUG
-
Placebo tablets
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Takeda
Study Design
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-07-31
- Primary Completion
- 2013-08-31
- Completion
- 2013-08-31
Countries
- Mexico
Study Locations
More Related Trials
-
Assessment of Onset, Safety & Toleration of UK-369,003 in Male Erectile Dysfunction
NCT00141349 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Udenafil to Treat Erectile Dysfunction
NCT01774864 ·Status: COMPLETED ·Phase: PHASE3
-
Safety Study of Once-a-Day Dosing of Udenafil to Treat Erectile Dysfunction
NCT01901640 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment Of Duration Of Action, Safety & Toleration Of UK369,003 and Cialis In Patients With Erectile Dysfunction
NCT00174486 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of 2.5mg and 5mg Tadalafil Given Once a Day to Men With Erectile Dysfunction
NCT00381732 ·Status: COMPLETED ·Phase: PHASE3
-
Shock Wave vs. On-demand Tadalafil for Erectile Dysfunction
NCT05199727 ·Status: UNKNOWN ·Phase: NA
-
Safety And Efficacy Of L-Arginine Monotherapy Versus Tadalafil Monotherapy Versus Their Combination In Men With Erectile Dysfunction; A Prospective Randomized Study
NCT06947265 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II
NCT03905018 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study Investigating the Safety, Tolerability, Drug Levels and Drug Effect of BMS-986278 in Healthy Adult Participants (Part 1) and Japanese Participants (Part 2)
NCT05684289 ·Status: COMPLETED ·Phase: PHASE1
-
To Determine How Different Doses of Tadalafil Work on Getting and Keeping an Erection 26 or 36 Hours After Taking
NCT00547508 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation
NCT00219635 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Tadalafil Once a Day in Men With Erectile Dysfunction
NCT00836693 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate the Safety and Toleration of Single Dose Sildenafil in Subjects Receiving Chronic UK-369,0031
NCT00814736 ·Status: COMPLETED ·Phase: PHASE1
-
Low-intensity Shockwaves Therapy + Tadalafil 5mg for the Treatment of Severe Erectile Dysfunction
NCT03642366 ·Status: UNKNOWN ·Phase: NA
-
Study the Safety and Effectiveness of Tadalafil in Men With Problems Getting or Maintaining an Erection When Taken Prior to Desiring an Erection
NCT00547495 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction
NCT05043896 ·Status: COMPLETED ·Phase: NA
-
Low Intensity Shockwaves Therapy for the Treatment of Erectile Dysfunction. 12- Month Follow-Up
NCT03670628 ·Status: TERMINATED ·Phase: NA
-
Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia
NCT00386009 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Determine Safety and Effectiveness of Tadalafil on Prostate Related Sex Organ/Urinary Tract Problems
NCT00547625 ·Status: COMPLETED ·Phase: PHASE2
-
Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life
NCT00422734 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing The Effect of Tadalafil 5 mg/Day to Sildenafil 25 mg/Day on Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Erectile Dysfunction Patients; and Comparison of Clinical Response
NCT05466695 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil
NCT00903981 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Dapoxetine
NCT01928563 ·Status: UNKNOWN ·Phase: PHASE1
-
The Use of Bioelectrical Stimulation in the Treatment of Erectile Dysfunction
NCT04363918 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial Studying the Efficacy and Safety of IP2018 in Depressed, Erectile Dysfunction (ED) Patients
NCT04686916 ·Status: UNKNOWN ·Phase: PHASE2